These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1766730)

  • 1. [Clinical significance of lipid metabolism in patients with chronic glomerulonephritis].
    Abdurakhmanova SK; Karimova NA
    Pediatriia; 1991; (11):110-1. PubMed ID: 1766730
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical assessment of lipid free-radical oxidation in chronic glomerulonephritis patients].
    Nazar PS; Galitskiĭ IaD; Martyniuk ES
    Ter Arkh; 1987; 59(9):104-6. PubMed ID: 3424171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The characteristics of the lipid peroxidation processes in patients with glomerulonephritis and a hematuric component].
    Dudar IO; Kolesnyk MO; Nikulina HH
    Lik Sprava; 1992 Aug; (8):48-52. PubMed ID: 1475926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of lipid peroxidation in the chronicity of glomerulonephritis with a hematuric component].
    Dudar IO; Kolesnyk MO; Nikulina HH; Pyrih LA
    Lik Sprava; 1993; (5-6):84-7. PubMed ID: 8209509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative damage of erythrocyte membrane in nephrotic syndrome.
    Mocan H; Aksoy A; Uydu HA; Mocan MC
    Pediatr Nephrol; 1999 May; 13(4):326-32. PubMed ID: 10454784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current state of the problem of lipid metabolism in patients with kidney diseases].
    Storozhenko AA
    Klin Med (Mosk); 1973 Oct; 51(10):28-30. PubMed ID: 4787276
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid abnormalities and peroxidation of erythrocytes in nephrotic syndrome.
    Clemens MR; Bursa-Zanetti Z
    Nephron; 1989; 53(4):325-9. PubMed ID: 2601799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma lipids in patients with chronic glomerulonephritis].
    Kolmakova EV
    Urol Nefrol (Mosk); 1990; (1):16-9. PubMed ID: 2336751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid peroxidation and the system of antioxidant protection in patients with chronic glomerulonephritis and normal kidney azoturic function].
    Riabov SI; Kulikova AI; Tugusheva FA; Zubina IM; Kozlov VV
    Ter Arkh; 1995; 67(12):33-7. PubMed ID: 8820054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [alpha-Lipoprotein cholesterol content of the blood serum in nephrotic syndrome].
    Nikiforova NV; Sokolovskaia IV; Riaposova IK; Poliantseva LR
    Ter Arkh; 1982; 54(7):57-61. PubMed ID: 7135225
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the lipid and fatty acid composition of the blood serum in subjects with glomerulonephrits with the nephrotic syndrome].
    Pisano L; Lombardi D; Spanò G
    Boll Soc Ital Cardiol; 1967; 12(1):27-36. PubMed ID: 5596746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Features of lipid peroxidation in the blood of patients with chronic glomerulonephritis at the stage of renal dysfunction in the presence of nephrotic syndrome].
    Tugusheva FA; Kulikova AI; Zubina IM
    Vopr Med Khim; 1993; 39(3):18-21. PubMed ID: 8333180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid peroxides in the plasma of patients with chronic glomerulonephritis of the nephrotic type].
    Nikiforova NV; Sokolovskaia IV; Gonchar NA
    Ter Arkh; 1983; 55(6):39-41. PubMed ID: 6612619
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of cell membrane damage in the development of hormone-resistant kidney diseases in children].
    Krylov VI; Petrushina AD; Moreva GV; Grannik GK; Durygin AN
    Vopr Med Khim; 1987; 33(4):22-4. PubMed ID: 3660735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the serum lipid spectrum of glomerulonephritis patients].
    Nikulina GG; Petrun' NM; Pyrig LA; Mel'man NIa
    Vrach Delo; 1985 Oct; (10):20-4. PubMed ID: 4090424
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution to the selectivity index determination in nephrotic syndrome].
    Simon J; Kulich V; Láhn V; Levý J; Prokop J; Kohout J
    Z Gesamte Inn Med; 1968 Feb; 23(3):79-82. PubMed ID: 4175029
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in lipid metabolic indices in children with chronic kidney diseases under the influence of diet therapy].
    Korf II; Kisteneva GS; Levachev MM
    Vopr Pitan; 1980; (2):40-4. PubMed ID: 7368672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Main aspects of studying lipid metabolism in clinical nephrology].
    Pyrig LA; Mel'man NIa; Petrun' NM; Nikulina GG; Anishchenko VM
    Ter Arkh; 1984; 56(7):28-31. PubMed ID: 6484829
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipid metabolic disorders and lipid peroxidation in patients with the nephrotic syndrome].
    Shishkin AN; Kolmakova EV; Ashirova KV
    Urol Nefrol (Mosk); 1994; (3):39-41. PubMed ID: 8079411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipid disturbances in the nephrotic syndrome].
    Chmielewski M; Zdrojewski Z; Rutkowski B
    Przegl Lek; 2003; 60(11):758-61. PubMed ID: 15058052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.